v3.26.1
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (10,487,532) $ (12,497,805)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 21,266 249,675
Amortization of internally developed software 1,470,873 2,036,981
Amortization of other intangible assets 191,555 191,555
Depreciation of property and equipment 68,474 65,712
Bad debt expense 59,863 705,724
Write-off of other intangible assets 525,145
Write-off of accounts receivable – unbilled 1,187,964
Write-off of accounts payable (75,000)
Write-off of internally developed software 1,871,064 327,387
Non-cash interest income related to accretion of discount on available-for-sale securities (28,976)
Loss from sales of available-for-sale securities 680
Loss on disposal of property and equipment 58
Change in operating assets and liabilities:    
Accounts receivable – unbilled 505,931
Accounts receivable 1,336,475 (903,329)
Inventory 45,110
Prepaid expenses and other current assets 194,325 27,187
Operating lease right-of-use asset 58,817 127,006
Security deposit 15,501
Accounts payable 1,240,043 272,123
Accrued expenses (549,544) (371,821)
Operating lease liability (43,369) (120,203)
Deferred revenue (168,173) (55,063)
Net cash used in operating activities (4,240,608) (8,263,713)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capitalization of intangible asset under development (1,000,000) (653,288)
Purchase of property and equipment (454) (31,546)
Purchase of leasehold improvements included in operating lease right-of-use asset (25,000)
Purchase of available-for-sale securities (460,932)
Proceeds from sales and maturities of available-for-sale securities 3,150,320
Net cash provided by (used in) investing activities (1,000,454) 1,979,554
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock in connection with At the Market Offering Agreement 1,494,414
Proceeds from issuance of common stock in with Securities Purchase Agreement 3,999,574 398,442
Proceeds from pre-funded warrants 4,600,022
Proceeds from issuance of common stock in connection with private placement 1,749,998
Proceeds from issuance of Series C convertible preferred stock in connection with PIPE financing 5,500,000
Payment of offering costs in connection with the issuance of common stock in connection with At the Market Offering Agreement (255,288)
Payment of offering costs in connection with the issuance of common stock in connection with pre-funded warrants and common shares (1,006,083) (366,189)
Repurchase of common stock purchase warrants exercisable under PIPE warrants (52,500)
Net cash provided by financing activities 10,243,489 5,818,901
Net increase (decrease) in cash and cash equivalents 5,002,427 (465,258)
Cash and cash equivalents at beginning of year 1,878,408 2,343,666
Cash and cash equivalents at end of year 6,880,835 1,878,408
Supplemental disclosure of cash flow information:    
Cash paid for interest 1,948 14,358
Supplemental disclosure of non-cash investing and financing activities:    
Non-cash amounts of lease liabilities reducing from terminating right-of-use assets 321,805
Non-cash adjustment to reduce lease liabilities and right-of-use assets due to lease termination 85,679
Stock issuance costs included in accounts payable and accrued expenses $ 7,023